This profile was created from public SEC EDGAR information. Is this you? Claim it, correct it or remove it.

Claim it Correct or add Remove it Report a problem

Paul Sweetnam

Chief Scientific Officer, Retension Pharmaceuticals, Inc., as of Oct 2026

From SEC EDGAR, not claimed yetUpdated Oct 20, 2026

Paul Sweetnam is Chief Scientific Officer at Retension Pharmaceuticals, Inc.

Chief Scientific Officer of Retension Pharmaceuticals, Inc.

Works at

RRetension Pharmaceuticals, Inc.Chief Scientific Officerfrom SEC EDGAR

as of Oct 2026, from an SEC filing